BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1050 related articles for article (PubMed ID: 15831824)

  • 1. Clostridium difficile toxins: mechanism of action and role in disease.
    Voth DE; Ballard JD
    Clin Microbiol Rev; 2005 Apr; 18(2):247-63. PubMed ID: 15831824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TcdB or not TcdB: a tale of two Clostridium difficile toxins.
    Carter GP; Awad MM; Kelly ML; Rood JI; Lyras D
    Future Microbiol; 2011 Feb; 6(2):121-3. PubMed ID: 21366410
    [No Abstract]   [Full Text] [Related]  

  • 3. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
    Chen S; Sun C; Wang H; Wang J
    Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine-71 phosphorylation of Rac1/Cdc42 diminishes the pathogenic effect of Clostridium difficile toxin A.
    Schoentaube J; Olling A; Tatge H; Just I; Gerhard R
    Cell Microbiol; 2009 Dec; 11(12):1816-26. PubMed ID: 19709124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the pathogenicity locus in Clostridium difficile strains.
    Cohen SH; Tang YJ; Silva J
    J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
    D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
    BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
    Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
    [No Abstract]   [Full Text] [Related]  

  • 10. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
    Zhang Y; Hamza T; Gao S; Feng H
    Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
    Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
    Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
    Zeiser J; Gerhard R; Just I; Pich A
    J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
    Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
    FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
    Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
    Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of Clostridium difficile toxins.
    Giesemann T; Egerer M; Jank T; Aktories K
    J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CdtR Regulates TcdA and TcdB Production in Clostridium difficile.
    Lyon SA; Hutton ML; Rood JI; Cheung JK; Lyras D
    PLoS Pathog; 2016 Jul; 12(7):e1005758. PubMed ID: 27414650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
    Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
    Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
    Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of toxin A and toxin B in the virulence of Clostridium difficile.
    Carter GP; Rood JI; Lyras D
    Trends Microbiol; 2012 Jan; 20(1):21-9. PubMed ID: 22154163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.